ImmunityBio’s hAd5 T-Cell COVID-19 Vaccine Candidate Shows Complete Protection of Airways in Non-Human Primates
FirstWord Pharma,
BARDA-sponsored study shows second-generation hAd5 vaccine candidate in both subcutaneous and room temperature oral…
BARDA-sponsored study shows second-generation hAd5 vaccine candidate in both subcutaneous and room temperature oral…
Dec. 11, 2020 02:48 UTC BARDA-sponsored study shows second-generation hAd5 vaccine candidate in both subcutaneous and room…
By protecting the nasal passages (the primary point of entry for the virus), the vaccine has the potential to reduce reinfection.
Dec. 11, 2020 02:48 UTC BARDA-sponsored study shows second-generation hAd5 vaccine candidate in both subcutaneous and room…